Medical Care
Global NDDS Cancer Therapy Market Research Report 2025
- May 05, 25
- ID: 226110
- Pages: 88
- Figures: 82
- Views: 33
The global market for NDDS Cancer Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for NDDS Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NDDS Cancer Therapy.
The NDDS Cancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NDDS Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NDDS Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Advanced Medical Isotope Corporation
Boston Scientific Corporation
CeloNova Biosciences, Inc.
Cook Medical, Inc.
Cospheric LLC
Eckert & Ziegler BEBIG
Kobo Products, Inc.
Medtronic plc
Merit Medical Systems, Inc.
Mo-Sci Corporation
Nanobiotix
Pfizer, Inc.
Polysciences, Inc.
Sirtex Medical, Inc.
Terumo Corporation
Segment by Type
Liquid Embolic
Embolization Particle
Nanoparticles
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NDDS Cancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for NDDS Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NDDS Cancer Therapy.
The NDDS Cancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global NDDS Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NDDS Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Advanced Medical Isotope Corporation
Boston Scientific Corporation
CeloNova Biosciences, Inc.
Cook Medical, Inc.
Cospheric LLC
Eckert & Ziegler BEBIG
Kobo Products, Inc.
Medtronic plc
Merit Medical Systems, Inc.
Mo-Sci Corporation
Nanobiotix
Pfizer, Inc.
Polysciences, Inc.
Sirtex Medical, Inc.
Terumo Corporation
Segment by Type
Liquid Embolic
Embolization Particle
Nanoparticles
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NDDS Cancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NDDS Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liquid Embolic
1.2.3 Embolization Particle
1.2.4 Nanoparticles
1.3 Market by Application
1.3.1 Global NDDS Cancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NDDS Cancer Therapy Market Perspective (2020-2031)
2.2 Global NDDS Cancer Therapy Growth Trends by Region
2.2.1 Global NDDS Cancer Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NDDS Cancer Therapy Historic Market Size by Region (2020-2025)
2.2.3 NDDS Cancer Therapy Forecasted Market Size by Region (2026-2031)
2.3 NDDS Cancer Therapy Market Dynamics
2.3.1 NDDS Cancer Therapy Industry Trends
2.3.2 NDDS Cancer Therapy Market Drivers
2.3.3 NDDS Cancer Therapy Market Challenges
2.3.4 NDDS Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NDDS Cancer Therapy Players by Revenue
3.1.1 Global Top NDDS Cancer Therapy Players by Revenue (2020-2025)
3.1.2 Global NDDS Cancer Therapy Revenue Market Share by Players (2020-2025)
3.2 Global NDDS Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NDDS Cancer Therapy Revenue
3.4 Global NDDS Cancer Therapy Market Concentration Ratio
3.4.1 Global NDDS Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NDDS Cancer Therapy Revenue in 2024
3.5 Global Key Players of NDDS Cancer Therapy Head office and Area Served
3.6 Global Key Players of NDDS Cancer Therapy, Product and Application
3.7 Global Key Players of NDDS Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NDDS Cancer Therapy Breakdown Data by Type
4.1 Global NDDS Cancer Therapy Historic Market Size by Type (2020-2025)
4.2 Global NDDS Cancer Therapy Forecasted Market Size by Type (2026-2031)
5 NDDS Cancer Therapy Breakdown Data by Application
5.1 Global NDDS Cancer Therapy Historic Market Size by Application (2020-2025)
5.2 Global NDDS Cancer Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NDDS Cancer Therapy Market Size (2020-2031)
6.2 North America NDDS Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NDDS Cancer Therapy Market Size by Country (2020-2025)
6.4 North America NDDS Cancer Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NDDS Cancer Therapy Market Size (2020-2031)
7.2 Europe NDDS Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NDDS Cancer Therapy Market Size by Country (2020-2025)
7.4 Europe NDDS Cancer Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NDDS Cancer Therapy Market Size (2020-2031)
8.2 Asia-Pacific NDDS Cancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NDDS Cancer Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific NDDS Cancer Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NDDS Cancer Therapy Market Size (2020-2031)
9.2 Latin America NDDS Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NDDS Cancer Therapy Market Size by Country (2020-2025)
9.4 Latin America NDDS Cancer Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NDDS Cancer Therapy Market Size (2020-2031)
10.2 Middle East & Africa NDDS Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NDDS Cancer Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa NDDS Cancer Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Advanced Medical Isotope Corporation
11.1.1 Advanced Medical Isotope Corporation Company Details
11.1.2 Advanced Medical Isotope Corporation Business Overview
11.1.3 Advanced Medical Isotope Corporation NDDS Cancer Therapy Introduction
11.1.4 Advanced Medical Isotope Corporation Revenue in NDDS Cancer Therapy Business (2020-2025)
11.1.5 Advanced Medical Isotope Corporation Recent Development
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Details
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation NDDS Cancer Therapy Introduction
11.2.4 Boston Scientific Corporation Revenue in NDDS Cancer Therapy Business (2020-2025)
11.2.5 Boston Scientific Corporation Recent Development
11.3 CeloNova Biosciences, Inc.
11.3.1 CeloNova Biosciences, Inc. Company Details
11.3.2 CeloNova Biosciences, Inc. Business Overview
11.3.3 CeloNova Biosciences, Inc. NDDS Cancer Therapy Introduction
11.3.4 CeloNova Biosciences, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.3.5 CeloNova Biosciences, Inc. Recent Development
11.4 Cook Medical, Inc.
11.4.1 Cook Medical, Inc. Company Details
11.4.2 Cook Medical, Inc. Business Overview
11.4.3 Cook Medical, Inc. NDDS Cancer Therapy Introduction
11.4.4 Cook Medical, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.4.5 Cook Medical, Inc. Recent Development
11.5 Cospheric LLC
11.5.1 Cospheric LLC Company Details
11.5.2 Cospheric LLC Business Overview
11.5.3 Cospheric LLC NDDS Cancer Therapy Introduction
11.5.4 Cospheric LLC Revenue in NDDS Cancer Therapy Business (2020-2025)
11.5.5 Cospheric LLC Recent Development
11.6 Eckert & Ziegler BEBIG
11.6.1 Eckert & Ziegler BEBIG Company Details
11.6.2 Eckert & Ziegler BEBIG Business Overview
11.6.3 Eckert & Ziegler BEBIG NDDS Cancer Therapy Introduction
11.6.4 Eckert & Ziegler BEBIG Revenue in NDDS Cancer Therapy Business (2020-2025)
11.6.5 Eckert & Ziegler BEBIG Recent Development
11.7 Kobo Products, Inc.
11.7.1 Kobo Products, Inc. Company Details
11.7.2 Kobo Products, Inc. Business Overview
11.7.3 Kobo Products, Inc. NDDS Cancer Therapy Introduction
11.7.4 Kobo Products, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.7.5 Kobo Products, Inc. Recent Development
11.8 Medtronic plc
11.8.1 Medtronic plc Company Details
11.8.2 Medtronic plc Business Overview
11.8.3 Medtronic plc NDDS Cancer Therapy Introduction
11.8.4 Medtronic plc Revenue in NDDS Cancer Therapy Business (2020-2025)
11.8.5 Medtronic plc Recent Development
11.9 Merit Medical Systems, Inc.
11.9.1 Merit Medical Systems, Inc. Company Details
11.9.2 Merit Medical Systems, Inc. Business Overview
11.9.3 Merit Medical Systems, Inc. NDDS Cancer Therapy Introduction
11.9.4 Merit Medical Systems, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.9.5 Merit Medical Systems, Inc. Recent Development
11.10 Mo-Sci Corporation
11.10.1 Mo-Sci Corporation Company Details
11.10.2 Mo-Sci Corporation Business Overview
11.10.3 Mo-Sci Corporation NDDS Cancer Therapy Introduction
11.10.4 Mo-Sci Corporation Revenue in NDDS Cancer Therapy Business (2020-2025)
11.10.5 Mo-Sci Corporation Recent Development
11.11 Nanobiotix
11.11.1 Nanobiotix Company Details
11.11.2 Nanobiotix Business Overview
11.11.3 Nanobiotix NDDS Cancer Therapy Introduction
11.11.4 Nanobiotix Revenue in NDDS Cancer Therapy Business (2020-2025)
11.11.5 Nanobiotix Recent Development
11.12 Pfizer, Inc.
11.12.1 Pfizer, Inc. Company Details
11.12.2 Pfizer, Inc. Business Overview
11.12.3 Pfizer, Inc. NDDS Cancer Therapy Introduction
11.12.4 Pfizer, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.12.5 Pfizer, Inc. Recent Development
11.13 Polysciences, Inc.
11.13.1 Polysciences, Inc. Company Details
11.13.2 Polysciences, Inc. Business Overview
11.13.3 Polysciences, Inc. NDDS Cancer Therapy Introduction
11.13.4 Polysciences, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.13.5 Polysciences, Inc. Recent Development
11.14 Sirtex Medical, Inc.
11.14.1 Sirtex Medical, Inc. Company Details
11.14.2 Sirtex Medical, Inc. Business Overview
11.14.3 Sirtex Medical, Inc. NDDS Cancer Therapy Introduction
11.14.4 Sirtex Medical, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.14.5 Sirtex Medical, Inc. Recent Development
11.15 Terumo Corporation
11.15.1 Terumo Corporation Company Details
11.15.2 Terumo Corporation Business Overview
11.15.3 Terumo Corporation NDDS Cancer Therapy Introduction
11.15.4 Terumo Corporation Revenue in NDDS Cancer Therapy Business (2020-2025)
11.15.5 Terumo Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NDDS Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liquid Embolic
1.2.3 Embolization Particle
1.2.4 Nanoparticles
1.3 Market by Application
1.3.1 Global NDDS Cancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NDDS Cancer Therapy Market Perspective (2020-2031)
2.2 Global NDDS Cancer Therapy Growth Trends by Region
2.2.1 Global NDDS Cancer Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 NDDS Cancer Therapy Historic Market Size by Region (2020-2025)
2.2.3 NDDS Cancer Therapy Forecasted Market Size by Region (2026-2031)
2.3 NDDS Cancer Therapy Market Dynamics
2.3.1 NDDS Cancer Therapy Industry Trends
2.3.2 NDDS Cancer Therapy Market Drivers
2.3.3 NDDS Cancer Therapy Market Challenges
2.3.4 NDDS Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NDDS Cancer Therapy Players by Revenue
3.1.1 Global Top NDDS Cancer Therapy Players by Revenue (2020-2025)
3.1.2 Global NDDS Cancer Therapy Revenue Market Share by Players (2020-2025)
3.2 Global NDDS Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by NDDS Cancer Therapy Revenue
3.4 Global NDDS Cancer Therapy Market Concentration Ratio
3.4.1 Global NDDS Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NDDS Cancer Therapy Revenue in 2024
3.5 Global Key Players of NDDS Cancer Therapy Head office and Area Served
3.6 Global Key Players of NDDS Cancer Therapy, Product and Application
3.7 Global Key Players of NDDS Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NDDS Cancer Therapy Breakdown Data by Type
4.1 Global NDDS Cancer Therapy Historic Market Size by Type (2020-2025)
4.2 Global NDDS Cancer Therapy Forecasted Market Size by Type (2026-2031)
5 NDDS Cancer Therapy Breakdown Data by Application
5.1 Global NDDS Cancer Therapy Historic Market Size by Application (2020-2025)
5.2 Global NDDS Cancer Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America NDDS Cancer Therapy Market Size (2020-2031)
6.2 North America NDDS Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America NDDS Cancer Therapy Market Size by Country (2020-2025)
6.4 North America NDDS Cancer Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NDDS Cancer Therapy Market Size (2020-2031)
7.2 Europe NDDS Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe NDDS Cancer Therapy Market Size by Country (2020-2025)
7.4 Europe NDDS Cancer Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NDDS Cancer Therapy Market Size (2020-2031)
8.2 Asia-Pacific NDDS Cancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific NDDS Cancer Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific NDDS Cancer Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NDDS Cancer Therapy Market Size (2020-2031)
9.2 Latin America NDDS Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America NDDS Cancer Therapy Market Size by Country (2020-2025)
9.4 Latin America NDDS Cancer Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NDDS Cancer Therapy Market Size (2020-2031)
10.2 Middle East & Africa NDDS Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa NDDS Cancer Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa NDDS Cancer Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Advanced Medical Isotope Corporation
11.1.1 Advanced Medical Isotope Corporation Company Details
11.1.2 Advanced Medical Isotope Corporation Business Overview
11.1.3 Advanced Medical Isotope Corporation NDDS Cancer Therapy Introduction
11.1.4 Advanced Medical Isotope Corporation Revenue in NDDS Cancer Therapy Business (2020-2025)
11.1.5 Advanced Medical Isotope Corporation Recent Development
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Details
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation NDDS Cancer Therapy Introduction
11.2.4 Boston Scientific Corporation Revenue in NDDS Cancer Therapy Business (2020-2025)
11.2.5 Boston Scientific Corporation Recent Development
11.3 CeloNova Biosciences, Inc.
11.3.1 CeloNova Biosciences, Inc. Company Details
11.3.2 CeloNova Biosciences, Inc. Business Overview
11.3.3 CeloNova Biosciences, Inc. NDDS Cancer Therapy Introduction
11.3.4 CeloNova Biosciences, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.3.5 CeloNova Biosciences, Inc. Recent Development
11.4 Cook Medical, Inc.
11.4.1 Cook Medical, Inc. Company Details
11.4.2 Cook Medical, Inc. Business Overview
11.4.3 Cook Medical, Inc. NDDS Cancer Therapy Introduction
11.4.4 Cook Medical, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.4.5 Cook Medical, Inc. Recent Development
11.5 Cospheric LLC
11.5.1 Cospheric LLC Company Details
11.5.2 Cospheric LLC Business Overview
11.5.3 Cospheric LLC NDDS Cancer Therapy Introduction
11.5.4 Cospheric LLC Revenue in NDDS Cancer Therapy Business (2020-2025)
11.5.5 Cospheric LLC Recent Development
11.6 Eckert & Ziegler BEBIG
11.6.1 Eckert & Ziegler BEBIG Company Details
11.6.2 Eckert & Ziegler BEBIG Business Overview
11.6.3 Eckert & Ziegler BEBIG NDDS Cancer Therapy Introduction
11.6.4 Eckert & Ziegler BEBIG Revenue in NDDS Cancer Therapy Business (2020-2025)
11.6.5 Eckert & Ziegler BEBIG Recent Development
11.7 Kobo Products, Inc.
11.7.1 Kobo Products, Inc. Company Details
11.7.2 Kobo Products, Inc. Business Overview
11.7.3 Kobo Products, Inc. NDDS Cancer Therapy Introduction
11.7.4 Kobo Products, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.7.5 Kobo Products, Inc. Recent Development
11.8 Medtronic plc
11.8.1 Medtronic plc Company Details
11.8.2 Medtronic plc Business Overview
11.8.3 Medtronic plc NDDS Cancer Therapy Introduction
11.8.4 Medtronic plc Revenue in NDDS Cancer Therapy Business (2020-2025)
11.8.5 Medtronic plc Recent Development
11.9 Merit Medical Systems, Inc.
11.9.1 Merit Medical Systems, Inc. Company Details
11.9.2 Merit Medical Systems, Inc. Business Overview
11.9.3 Merit Medical Systems, Inc. NDDS Cancer Therapy Introduction
11.9.4 Merit Medical Systems, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.9.5 Merit Medical Systems, Inc. Recent Development
11.10 Mo-Sci Corporation
11.10.1 Mo-Sci Corporation Company Details
11.10.2 Mo-Sci Corporation Business Overview
11.10.3 Mo-Sci Corporation NDDS Cancer Therapy Introduction
11.10.4 Mo-Sci Corporation Revenue in NDDS Cancer Therapy Business (2020-2025)
11.10.5 Mo-Sci Corporation Recent Development
11.11 Nanobiotix
11.11.1 Nanobiotix Company Details
11.11.2 Nanobiotix Business Overview
11.11.3 Nanobiotix NDDS Cancer Therapy Introduction
11.11.4 Nanobiotix Revenue in NDDS Cancer Therapy Business (2020-2025)
11.11.5 Nanobiotix Recent Development
11.12 Pfizer, Inc.
11.12.1 Pfizer, Inc. Company Details
11.12.2 Pfizer, Inc. Business Overview
11.12.3 Pfizer, Inc. NDDS Cancer Therapy Introduction
11.12.4 Pfizer, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.12.5 Pfizer, Inc. Recent Development
11.13 Polysciences, Inc.
11.13.1 Polysciences, Inc. Company Details
11.13.2 Polysciences, Inc. Business Overview
11.13.3 Polysciences, Inc. NDDS Cancer Therapy Introduction
11.13.4 Polysciences, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.13.5 Polysciences, Inc. Recent Development
11.14 Sirtex Medical, Inc.
11.14.1 Sirtex Medical, Inc. Company Details
11.14.2 Sirtex Medical, Inc. Business Overview
11.14.3 Sirtex Medical, Inc. NDDS Cancer Therapy Introduction
11.14.4 Sirtex Medical, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025)
11.14.5 Sirtex Medical, Inc. Recent Development
11.15 Terumo Corporation
11.15.1 Terumo Corporation Company Details
11.15.2 Terumo Corporation Business Overview
11.15.3 Terumo Corporation NDDS Cancer Therapy Introduction
11.15.4 Terumo Corporation Revenue in NDDS Cancer Therapy Business (2020-2025)
11.15.5 Terumo Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global NDDS Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Liquid Embolic
Table 3. Key Players of Embolization Particle
Table 4. Key Players of Nanoparticles
Table 5. Global NDDS Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global NDDS Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global NDDS Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global NDDS Cancer Therapy Market Share by Region (2020-2025)
Table 9. Global NDDS Cancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global NDDS Cancer Therapy Market Share by Region (2026-2031)
Table 11. NDDS Cancer Therapy Market Trends
Table 12. NDDS Cancer Therapy Market Drivers
Table 13. NDDS Cancer Therapy Market Challenges
Table 14. NDDS Cancer Therapy Market Restraints
Table 15. Global NDDS Cancer Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global NDDS Cancer Therapy Market Share by Players (2020-2025)
Table 17. Global Top NDDS Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NDDS Cancer Therapy as of 2024)
Table 18. Ranking of Global Top NDDS Cancer Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by NDDS Cancer Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of NDDS Cancer Therapy, Headquarters and Area Served
Table 21. Global Key Players of NDDS Cancer Therapy, Product and Application
Table 22. Global Key Players of NDDS Cancer Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global NDDS Cancer Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global NDDS Cancer Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global NDDS Cancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global NDDS Cancer Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global NDDS Cancer Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global NDDS Cancer Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global NDDS Cancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global NDDS Cancer Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America NDDS Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America NDDS Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America NDDS Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe NDDS Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe NDDS Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe NDDS Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific NDDS Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific NDDS Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific NDDS Cancer Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America NDDS Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America NDDS Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America NDDS Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa NDDS Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa NDDS Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa NDDS Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Advanced Medical Isotope Corporation Company Details
Table 48. Advanced Medical Isotope Corporation Business Overview
Table 49. Advanced Medical Isotope Corporation NDDS Cancer Therapy Product
Table 50. Advanced Medical Isotope Corporation Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 51. Advanced Medical Isotope Corporation Recent Development
Table 52. Boston Scientific Corporation Company Details
Table 53. Boston Scientific Corporation Business Overview
Table 54. Boston Scientific Corporation NDDS Cancer Therapy Product
Table 55. Boston Scientific Corporation Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 56. Boston Scientific Corporation Recent Development
Table 57. CeloNova Biosciences, Inc. Company Details
Table 58. CeloNova Biosciences, Inc. Business Overview
Table 59. CeloNova Biosciences, Inc. NDDS Cancer Therapy Product
Table 60. CeloNova Biosciences, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 61. CeloNova Biosciences, Inc. Recent Development
Table 62. Cook Medical, Inc. Company Details
Table 63. Cook Medical, Inc. Business Overview
Table 64. Cook Medical, Inc. NDDS Cancer Therapy Product
Table 65. Cook Medical, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 66. Cook Medical, Inc. Recent Development
Table 67. Cospheric LLC Company Details
Table 68. Cospheric LLC Business Overview
Table 69. Cospheric LLC NDDS Cancer Therapy Product
Table 70. Cospheric LLC Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 71. Cospheric LLC Recent Development
Table 72. Eckert & Ziegler BEBIG Company Details
Table 73. Eckert & Ziegler BEBIG Business Overview
Table 74. Eckert & Ziegler BEBIG NDDS Cancer Therapy Product
Table 75. Eckert & Ziegler BEBIG Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 76. Eckert & Ziegler BEBIG Recent Development
Table 77. Kobo Products, Inc. Company Details
Table 78. Kobo Products, Inc. Business Overview
Table 79. Kobo Products, Inc. NDDS Cancer Therapy Product
Table 80. Kobo Products, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 81. Kobo Products, Inc. Recent Development
Table 82. Medtronic plc Company Details
Table 83. Medtronic plc Business Overview
Table 84. Medtronic plc NDDS Cancer Therapy Product
Table 85. Medtronic plc Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 86. Medtronic plc Recent Development
Table 87. Merit Medical Systems, Inc. Company Details
Table 88. Merit Medical Systems, Inc. Business Overview
Table 89. Merit Medical Systems, Inc. NDDS Cancer Therapy Product
Table 90. Merit Medical Systems, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 91. Merit Medical Systems, Inc. Recent Development
Table 92. Mo-Sci Corporation Company Details
Table 93. Mo-Sci Corporation Business Overview
Table 94. Mo-Sci Corporation NDDS Cancer Therapy Product
Table 95. Mo-Sci Corporation Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 96. Mo-Sci Corporation Recent Development
Table 97. Nanobiotix Company Details
Table 98. Nanobiotix Business Overview
Table 99. Nanobiotix NDDS Cancer Therapy Product
Table 100. Nanobiotix Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 101. Nanobiotix Recent Development
Table 102. Pfizer, Inc. Company Details
Table 103. Pfizer, Inc. Business Overview
Table 104. Pfizer, Inc. NDDS Cancer Therapy Product
Table 105. Pfizer, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 106. Pfizer, Inc. Recent Development
Table 107. Polysciences, Inc. Company Details
Table 108. Polysciences, Inc. Business Overview
Table 109. Polysciences, Inc. NDDS Cancer Therapy Product
Table 110. Polysciences, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 111. Polysciences, Inc. Recent Development
Table 112. Sirtex Medical, Inc. Company Details
Table 113. Sirtex Medical, Inc. Business Overview
Table 114. Sirtex Medical, Inc. NDDS Cancer Therapy Product
Table 115. Sirtex Medical, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 116. Sirtex Medical, Inc. Recent Development
Table 117. Terumo Corporation Company Details
Table 118. Terumo Corporation Business Overview
Table 119. Terumo Corporation NDDS Cancer Therapy Product
Table 120. Terumo Corporation Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 121. Terumo Corporation Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. NDDS Cancer Therapy Picture
Figure 2. Global NDDS Cancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NDDS Cancer Therapy Market Share by Type: 2024 VS 2031
Figure 4. Liquid Embolic Features
Figure 5. Embolization Particle Features
Figure 6. Nanoparticles Features
Figure 7. Global NDDS Cancer Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global NDDS Cancer Therapy Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. NDDS Cancer Therapy Report Years Considered
Figure 13. Global NDDS Cancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global NDDS Cancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global NDDS Cancer Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global NDDS Cancer Therapy Market Share by Players in 2024
Figure 17. Global Top NDDS Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NDDS Cancer Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by NDDS Cancer Therapy Revenue in 2024
Figure 19. North America NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America NDDS Cancer Therapy Market Share by Country (2020-2031)
Figure 21. United States NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe NDDS Cancer Therapy Market Share by Country (2020-2031)
Figure 25. Germany NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific NDDS Cancer Therapy Market Share by Region (2020-2031)
Figure 33. China NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America NDDS Cancer Therapy Market Share by Country (2020-2031)
Figure 41. Mexico NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa NDDS Cancer Therapy Market Share by Country (2020-2031)
Figure 45. Turkey NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Advanced Medical Isotope Corporation Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 49. Boston Scientific Corporation Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 50. CeloNova Biosciences, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 51. Cook Medical, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 52. Cospheric LLC Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 53. Eckert & Ziegler BEBIG Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 54. Kobo Products, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 55. Medtronic plc Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 56. Merit Medical Systems, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 57. Mo-Sci Corporation Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 58. Nanobiotix Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 59. Pfizer, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 60. Polysciences, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 61. Sirtex Medical, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 62. Terumo Corporation Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global NDDS Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Liquid Embolic
Table 3. Key Players of Embolization Particle
Table 4. Key Players of Nanoparticles
Table 5. Global NDDS Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global NDDS Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global NDDS Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global NDDS Cancer Therapy Market Share by Region (2020-2025)
Table 9. Global NDDS Cancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global NDDS Cancer Therapy Market Share by Region (2026-2031)
Table 11. NDDS Cancer Therapy Market Trends
Table 12. NDDS Cancer Therapy Market Drivers
Table 13. NDDS Cancer Therapy Market Challenges
Table 14. NDDS Cancer Therapy Market Restraints
Table 15. Global NDDS Cancer Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global NDDS Cancer Therapy Market Share by Players (2020-2025)
Table 17. Global Top NDDS Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NDDS Cancer Therapy as of 2024)
Table 18. Ranking of Global Top NDDS Cancer Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by NDDS Cancer Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of NDDS Cancer Therapy, Headquarters and Area Served
Table 21. Global Key Players of NDDS Cancer Therapy, Product and Application
Table 22. Global Key Players of NDDS Cancer Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global NDDS Cancer Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global NDDS Cancer Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global NDDS Cancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global NDDS Cancer Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global NDDS Cancer Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global NDDS Cancer Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global NDDS Cancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global NDDS Cancer Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America NDDS Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America NDDS Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America NDDS Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe NDDS Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe NDDS Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe NDDS Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific NDDS Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific NDDS Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific NDDS Cancer Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America NDDS Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America NDDS Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America NDDS Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa NDDS Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa NDDS Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa NDDS Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Advanced Medical Isotope Corporation Company Details
Table 48. Advanced Medical Isotope Corporation Business Overview
Table 49. Advanced Medical Isotope Corporation NDDS Cancer Therapy Product
Table 50. Advanced Medical Isotope Corporation Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 51. Advanced Medical Isotope Corporation Recent Development
Table 52. Boston Scientific Corporation Company Details
Table 53. Boston Scientific Corporation Business Overview
Table 54. Boston Scientific Corporation NDDS Cancer Therapy Product
Table 55. Boston Scientific Corporation Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 56. Boston Scientific Corporation Recent Development
Table 57. CeloNova Biosciences, Inc. Company Details
Table 58. CeloNova Biosciences, Inc. Business Overview
Table 59. CeloNova Biosciences, Inc. NDDS Cancer Therapy Product
Table 60. CeloNova Biosciences, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 61. CeloNova Biosciences, Inc. Recent Development
Table 62. Cook Medical, Inc. Company Details
Table 63. Cook Medical, Inc. Business Overview
Table 64. Cook Medical, Inc. NDDS Cancer Therapy Product
Table 65. Cook Medical, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 66. Cook Medical, Inc. Recent Development
Table 67. Cospheric LLC Company Details
Table 68. Cospheric LLC Business Overview
Table 69. Cospheric LLC NDDS Cancer Therapy Product
Table 70. Cospheric LLC Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 71. Cospheric LLC Recent Development
Table 72. Eckert & Ziegler BEBIG Company Details
Table 73. Eckert & Ziegler BEBIG Business Overview
Table 74. Eckert & Ziegler BEBIG NDDS Cancer Therapy Product
Table 75. Eckert & Ziegler BEBIG Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 76. Eckert & Ziegler BEBIG Recent Development
Table 77. Kobo Products, Inc. Company Details
Table 78. Kobo Products, Inc. Business Overview
Table 79. Kobo Products, Inc. NDDS Cancer Therapy Product
Table 80. Kobo Products, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 81. Kobo Products, Inc. Recent Development
Table 82. Medtronic plc Company Details
Table 83. Medtronic plc Business Overview
Table 84. Medtronic plc NDDS Cancer Therapy Product
Table 85. Medtronic plc Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 86. Medtronic plc Recent Development
Table 87. Merit Medical Systems, Inc. Company Details
Table 88. Merit Medical Systems, Inc. Business Overview
Table 89. Merit Medical Systems, Inc. NDDS Cancer Therapy Product
Table 90. Merit Medical Systems, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 91. Merit Medical Systems, Inc. Recent Development
Table 92. Mo-Sci Corporation Company Details
Table 93. Mo-Sci Corporation Business Overview
Table 94. Mo-Sci Corporation NDDS Cancer Therapy Product
Table 95. Mo-Sci Corporation Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 96. Mo-Sci Corporation Recent Development
Table 97. Nanobiotix Company Details
Table 98. Nanobiotix Business Overview
Table 99. Nanobiotix NDDS Cancer Therapy Product
Table 100. Nanobiotix Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 101. Nanobiotix Recent Development
Table 102. Pfizer, Inc. Company Details
Table 103. Pfizer, Inc. Business Overview
Table 104. Pfizer, Inc. NDDS Cancer Therapy Product
Table 105. Pfizer, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 106. Pfizer, Inc. Recent Development
Table 107. Polysciences, Inc. Company Details
Table 108. Polysciences, Inc. Business Overview
Table 109. Polysciences, Inc. NDDS Cancer Therapy Product
Table 110. Polysciences, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 111. Polysciences, Inc. Recent Development
Table 112. Sirtex Medical, Inc. Company Details
Table 113. Sirtex Medical, Inc. Business Overview
Table 114. Sirtex Medical, Inc. NDDS Cancer Therapy Product
Table 115. Sirtex Medical, Inc. Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 116. Sirtex Medical, Inc. Recent Development
Table 117. Terumo Corporation Company Details
Table 118. Terumo Corporation Business Overview
Table 119. Terumo Corporation NDDS Cancer Therapy Product
Table 120. Terumo Corporation Revenue in NDDS Cancer Therapy Business (2020-2025) & (US$ Million)
Table 121. Terumo Corporation Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. NDDS Cancer Therapy Picture
Figure 2. Global NDDS Cancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global NDDS Cancer Therapy Market Share by Type: 2024 VS 2031
Figure 4. Liquid Embolic Features
Figure 5. Embolization Particle Features
Figure 6. Nanoparticles Features
Figure 7. Global NDDS Cancer Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global NDDS Cancer Therapy Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. NDDS Cancer Therapy Report Years Considered
Figure 13. Global NDDS Cancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global NDDS Cancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global NDDS Cancer Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global NDDS Cancer Therapy Market Share by Players in 2024
Figure 17. Global Top NDDS Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NDDS Cancer Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by NDDS Cancer Therapy Revenue in 2024
Figure 19. North America NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America NDDS Cancer Therapy Market Share by Country (2020-2031)
Figure 21. United States NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe NDDS Cancer Therapy Market Share by Country (2020-2031)
Figure 25. Germany NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific NDDS Cancer Therapy Market Share by Region (2020-2031)
Figure 33. China NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America NDDS Cancer Therapy Market Share by Country (2020-2031)
Figure 41. Mexico NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa NDDS Cancer Therapy Market Share by Country (2020-2031)
Figure 45. Turkey NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE NDDS Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Advanced Medical Isotope Corporation Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 49. Boston Scientific Corporation Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 50. CeloNova Biosciences, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 51. Cook Medical, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 52. Cospheric LLC Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 53. Eckert & Ziegler BEBIG Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 54. Kobo Products, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 55. Medtronic plc Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 56. Merit Medical Systems, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 57. Mo-Sci Corporation Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 58. Nanobiotix Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 59. Pfizer, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 60. Polysciences, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 61. Sirtex Medical, Inc. Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 62. Terumo Corporation Revenue Growth Rate in NDDS Cancer Therapy Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232